<DOC>
	<DOC>NCT01804998</DOC>
	<brief_summary>Laparoscopic sentinel lymph node biopsy and stomach preserving surgery in early gastric cancer is less invasive method which can increase quality of life. For last two years, multicenter quality control study (Phase II) has been performed in Korea and tolerable results were observed. Based on these results, multicenter phase III trial is required to validate the clinical role of laparoscopic sentinel lymph node biopsy.</brief_summary>
	<brief_title>Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy</brief_title>
	<detailed_description>The final analyses include the modificed intention to treatment analysis (full anlaysis set) and Per Protocol anlaysis (including patients who underwent assiged surgery without agreement withdrawal).</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>single lesion of adenocarcinoma in preoperative endoscopic biopsy clinical stage T1N0 in the preoperative evaluation of endoscopy and computed tomography tumor size: less than 3cm location: 2cm far from the pylorus or cardia aged 20 to 80 ECOG 0 or 1 patient who signed the agreement patient who is suspected to underwent laparoscopy assisted gastrectomy indication of endoscopic submucosal resection inoperable due to poor cardiac, pulmonary function pregnant having allergic reaction, previous upper abdominal surgery except laparoscopic cholecystectomy, previous radiation therapy to upper abdomen diagnosed as malignancy within 5 years except carcinoma in situ of cervix cancer and thyroid cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>laparoscopic sentinel lymph node biopsy</keyword>
	<keyword>phase 3</keyword>
	<keyword>early gastric cancer</keyword>
</DOC>